Our services


Our team is experienced in providing service in all phases of clinical development for pharmaceutical, medical device and functional food trials. We provide a full-service concept offering the entire study team for all functions, or professionals working as a part of the customers’ study team.

Read More

Data Services

Crown CRO has expanded its own services offering to include Data Management and Biostatistics, with its newly implemented Data Services Function. A vital part of the clinical trials life cycle, Data services has the capability to operate on a Global level for trials of any size.

Read More

Medical Device

A new level of customer attention, flexibility and reliability is brought to you by Crown CRO from early regulatory consulting all the way to medical device trials and CE-mark and 510(k) submissions.

Read More

Quality Assurance

Crown CRO Quality Assurance Services can support you to develop, implement and update your quality systems and procedures to conform to current guidelines and regulations. We also provide auditing services to help you identify your strengths, as well as areas that need improvement.

Read More


Meeting clinical study or post-marketing pharmacovigilance (PV) obligations is a key requirement for your company. If you need resources or know-how, the Crown CRO PV team can offer personalized services either to strengthen your own PV functions or as a full-service PV solution.

Read More

Medical Language Services

Do you need high quality translations for your clinical trials, drug regulatory affairs or pharmaceutical marketing? Crown CRO Medical Translations can offer you all of those and much more. Go to our Medical Translations page for more information and contact details.

Read More

Regulatory Affairs

Our Regulatory Affairs function supports your goals by providing a broad variety of flexible and cost-effective Regulatory Affairs services. Our main services cover clinical trial application submissions, regulatory strategies and documentation as well as regulatory procedures for pharmaceuticals and medical devices.

Read More

Study Rescue Service

Crown CRO supports pharma and biotech companies and other CROs with study rescue operations. A fresh point of view, new ideas or simple support and motivation can help to put the study back on track and bring it to a successful conclusion.

Read More

Our experience

Crown CRO has a broad therapeutic expertise and our team has been involved in more than 900 clinical trials in numerous indications.

We have performed trials in all phases of clinical development. We have played various roles in our projects from managing full-service trials and programs globally and regionally. We can also support in regional parts of the trials, as well as providing resources and ad hoc services in our countries. We also provide Study Rescue Services.

The local knowledge of our experienced team is what is behind of our success. The knowledge of local regulatory processes combined with a wide network of investigators and Key Opinion Leaders enables us to successfully complete our commitments to our customers.

Core indications:

We provide our professionalism, in-depth experience and service-oriented way of working to focus on delivering the high quality data on time and within budget.

Our Company

Crown CRO is a privately owned Finnish CRO founded in 2005. Our headquarters is in Espoo, which is located in Finland’s capital city region. Crown CRO provides full service clinical operations or any services related to clinical operations.

Our 125+ professionals are located in our offices in Finland, Sweden, Denmark, Norway, Estonia, Latvia and Lithuania. Our operations also cover Iceland, Belarus, Belgium and Georgia. We also have a worldwide network of partners.

Crown CRO provides services in the pharmaceutical, biotechnology, functional food and medical device sectors, as well as to other contract research organizations. Our services also cover quality assurance, pharmacovigilance, regulatory, and translation services.

We have been involved in over 900 clinical studies in more than 18 countries in various therapeutic areas and in all phases of clinical development. We currently have 100 active clinical trials ongoing.

Our vast experience enables us to serve our customers in coordinating trials from early phases up to late phase and real-world studies with high quality data and on time delivery within budget.

Our Mission
Our mission is to deliver top quality services to our customers while providing an ideal working environment for our employees.





Full attention and personalized service.

Involving companies in the planning of flexible exploitation of health data

In Finland, the health data collected in national registries already serves fairly well the needs of clinical care and academic basic research, and statistical purposes. However, the use of such data in company-driven research is limited, even though applied research is needed for developing new treatment methods, drugs and well-being products. The PreMed project launched by VTT introduces a corporate perspective to the planning of a national service operator to coordinate the use of health data.

Read more

Sigrid Therapeutics AB Initiates a Clinical Trial of SiPore15™ for Treatment of Prediabetes with Engagement from Crown CRO

Stockholm, January 28th 2019 – Sigrid Therapeutics AB (Sigrid) and Crown CRO (Crown) today announced the initiation of the STAR clinical trial testing the efficacy and safety ofthe orally administered medical device, SiPore15™. The goal of this clinical trial is to demonstrate an improvement in measurements of metabolic disorder in patients with prediabetes and newly diagnosed untreated type 2 diabetes.

Read more

Adial Pharmaceuticals Partners With Crown CRO to Begin Phase 3 Clinical Trials of AD04 for the Treatment of Alcohol Use Disorder

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, and Crown CRO, a contract research organization based in Finland, today announced Crown’s engagement to manage Adial’s Phase 3 clinical trial for AD04 for the treatment of alcohol use disorder (AUD). The FDA approved protocol for this Phase 3 clinical trial is a 24-week trial with 290 patients in 30 clinical sites in 5 European countries.

Read more

Finnish high-end expertise in drug research: The 2018 top talents in clinical drug trials awarded

[English summary of the announcement released by the Pharmaceutical Information Centre on 25 Oct 2018] 

For the fifth time in a row, the Investigator, Study Nurse and CRA (Clinical Research Associate) of the Year were nominated by Finnish clinical research professionals. In a clinical drug trial, the investigator, study nurse and CRA form a study team, each of them playing a significant role in terms of a safe and successful drug trial. This year’s winners were nominated and awarded with diplomas during the Clinical Trials Forum organized by the Pharmaceutical Information Centre in Helsinki on 25 October 2018.

Read more